We've got news for you.

Register on BusinessLIVE at no cost to receive newsletters, read exclusive articles & more.
Register now

Cape Town drug company Afrigen has become the first African laboratory to partner with the US government’s Vaccine Research Centre to develop mRNA vaccine technology in SA and low-income countries.           

The collaboration, announced on Friday, also comes after SA scientists led by Prof Patrick Arbuthnot, head of Wits University’s antiviral gene therapy research unit, were able to create an mRNA vaccine against Covid-19 from limited publicly available information. ..

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now

Would you like to comment on this article?
Register (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.

Commenting is subject to our house rules.